Search / 624 results found

  • Updated

SEATTLE, March 2, 2021 /PRNewswire/ -- Presage Biosciences, Inc., a biotechnology company pioneering a new cancer drug development approach using its Comparative In Vivo Oncology (CIVO®) intratumoral microdosing platform, today announced the closing of a $13 million financing and commencement of new research collaborations with Merck, known as MSD outside of the United States and Canada, and Maverick Therapeutics.

  • Updated

OLYMPIA — In a stunning 5-4 ruling, the Washington State Supreme Court on Feb. 25 said the state’s felony drug possession law is ruled unconstitutional, and now null and void.